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COHORT PROFILE
Cohort Profile: The Cambridge City over-75s
Cohort (CC75C)
Jane Fleming,1* Emily Zhao,1 Daniel W O’Connor,1,2 Penelope A Pollitt,1,2 Carol Brayne1 and
the CC75C study
The Cambridge City over-75s Cohort (CC75C), one of the largest
and longest-running population-based studies of the oldest old,
is celebrating its 21st birthday. Its origins and subsequent
evolution into one of the UK’s key ageing cohort studies lie in
the collaboration of many distinguished researchers, and its
ongoing importance owes much to the invaluable contribution
made by its many committed participants.
How did the study come about?
Sir Martin Roth is a key figure in the development of old age
psychiatry as it is today, and he made a major contribution to
research into dementia in the last half of the last century1–4
(Figure 1). The field of dementia epidemiology developed
naturally from his early work with hospital residents, which
linked the study of their mental disorders to examination of
their brains after death. In the 1980s questions were emerging
about the best patterns of care for people with dementia, early
detection and whether individuals would be best supported at
home or within institutions. In this context Sir Martin Roth,
Dr Peter Brook (old age psychiatry), Dr Bernard Reiss (general
practice) and Dr Felicia Huppert (psychology) combined forces
to seek funding from the Charles Wolfson Charitable Trust for a
population-based dementia study. They recruited Dr Daniel
O’Connor (old age psychiatry) and Dr Penelope Pollitt (anthro-
pology) to implement their ideas. The design started as a
mechanism to detect people in the earliest stages of dementia,
not yet perceived by their families, who could then be followed
and in whom different patterns of care might be investigated.
At that time a multidisciplinary community resource team was
being put together for different parts of Cambridge city, with
teams defined by geographical areas. In one area the team was
just starting up and usual care was available in the other area.
Although a randomized controlled trial would have been
desirable this was not held to be justified, and so the natural
experiment was observed instead.
Thus, beginning in 1985, this original survey measured the
prevalence of dementia,5 including the mildest stages,6 and
then followed over the next 2 years the evolution of patterns of
care,7 recognition of the onset of dementia8–11 and transitions
to long-term care.7
The opportunity to follow on from this ground-breaking work
was recognized by Professor Eugene Paykel who, along with
Dr Huppert and Dr Carol Brayne, successfully raised Medical
Research Council funding to carry out a study of new dementia
incidence amongst those who had not been diagnosed with
dementia by the original team.12,13 When the original project
ended the incidence study team became the stewards for the
total data set, and they have continued to follow-up this popula-
tion to the present day. Each phase had a new name—early
publications refer to the Hughes Hall Project for Later Life, so
called to reflect the support given by a college of Cambridge
University, and the incidence survey was launched 2 years
later as the Cambridge Project for Later Life, the name by which
participants still know the study. However, the study as a whole,
spanning over 20 years now, is known as the Cambridge City
over-75s Cohort14 (http://www.cc75c.group.cam.ac.uk).
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Figure 1 Sir Martin Roth
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Who is in the study sample?
The baseline study targeted all men and women aged 75 years
or older, who were registered with a selection of geographically
and socially representative practices in Cambridge, achieving
a 95% response rate. From this original survey of 2609 people,
2165 individuals formed the baseline sample for the ongoing
cohort study. This excluded one of the original general practices
because of differential recruitment, and also a small group
involved in a branch study. Survivors of this longitudinal cohort
have been followed-up on at least five further occasions and
sub-groups have been assessed more often.
Given the expected high attrition rates due to mortality, the
study has paid close attention to the importance of keeping
the sample representative by tracing survivors and using proxy
informants where a frail participant might otherwise have been
lost to follow-up. In the most recently completed survey, data
were gathered on 84% of those still alive—110 people, 90%
of them interviewed in person. At the time of going to press,
more than 50 people, all aged 95 years or more, are alive and
currently being surveyed again.
Table 1 describes the demographic characteristics of the
baseline sample population (aged 75–106, 65% women,
4% living in care) alongside the participants who completed
the last survey (aged 91–106, 82% women, 26% living in care).
Figure 2a and b illustrate the shifting age range over the
duration of the cohort study so far.
Key dimensions and measures
The study’s core themes—cognition and function in older
old age—cover multidisciplinary research interests as diverse
as neuropsychology, genetics, palliative care and psychiatry
with a range of investigations at various time-points including
bone strength, falls, physical performance and brain pathology.
Each survey has included a detailed cognitive assessment,
including at least the Mini-Mental State Examination
(MMSE),15 usually its extended version and, in the majority
of interviews, the Cambridge Cognitive Exam (CAMCOG).16
After a series of intensive assessments with purposely selected
sub-groups in the initial study stages, follow-up of the
full cohort continued with interviews every few years.
The flowchart in Figure 3 summarizes the main stages to date.
Interview data
The core data set comprises data collected from the six
main surveys to date using the CC75C structured schedule
administered by trained interviewers. This provides longitudinal
data on socio-demographic variables (e.g. place of residence,
household structure, marital status and social contact),
activities of daily living, use of health and social service,
health problems and medication. The interview schedule
has undergone slight revisions over the years with the addition
of new sections, such as questions on service use added in
Survey 3, but maintaining continuity of core measures has
remained a priority.
The CC75C study also holds other data resources collected
at different periods in the study to examine specific topics
of importance in ageing research.
CAMDEX assessments
After the baseline cognitive screening assessment, those who
scored 23 or below in the MMSE, and a sample of those
with MMSE scores 24 or 25, were assessed using the
Cambridge Mental Disorders of the Elderly Examination
(CAMDEX), a structured schedule specifically designed to
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Figure 2 (a) Age distribution of the CC75C baseline sample
(Survey 1¼Year 0). (b) Age distribution of the latest survivor sample
(Survey 6¼Year 17)
Table 1 Demographic characteristics of the baseline sample population
and of participants in the last survey completed
Year 0
(Baseline
sample)
[n¼ 2165]
Year 17
(Survey 6
sample)
[n¼ 110]
Age
Mean (SD) 81.3 (4.6) 94.4 (2.4)
Median 80.4 93.8
Inter-quartile range 77.6–84.0 92.7–95.8
Range 75.0–106.3 91.6–105.8
n (%) n (%)
Gender
Women 1409 (65) 90 (82)
Men 756 (35) 20 (18)
Place of residence
Living in the community
house/flat/granny flat 1892 (87) 62 (56)
Supported living
sheltered accommodation 182 (8) 19 (17)
Living in institutional care
residential/nursing home/
long-stay hospital
91 (4) 29 (26)
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detect mild dementia. The CAMDEX includes a mental state
examination, a psychiatric history, detailed cognitive testing,
and an interview with a proxy informant.
Biological resources
In the 3rd year of the study magnetic resonance imaging brain
scans were taken of a sub-sample following Survey 2. During
Survey 4 (Year 10) blood samples were gathered for genetic
studies from all participants who consented. In Survey 6 (Year
17) new physical measurements were recorded for the first
time: in addition to the usual CC75C questionnaire, the project
nurse conducted functional assessments and scanned heel
bones with quantitative ultrasound as part of this survey’s
focus on falls amongst over-90-year-olds.
Brain donation study
It was in Survey 2 that the brain donation programme began to
identify study participants willing to donate brain tissue after
their death. CC75C was the first study to approach individuals
from a population sample, aiming to represent both the demented
and non-demented, in order to examine the relationship of
findings during life and the appearance of the brain after death in
the whole population. The methods used to approach individuals
have been used in many other studies, most particularly the
MRC-Cognitive Function and Ageing Study.17 This programme is
still running, with 230 donations so far collected.
Other measures
In Survey 6 (Year 17) only, each participant was followed-up
intensively for 12 months, tracking the consequences of falls in
advanced old age—injuries, hospitalization and moves into
long-term care.
For the current survey (Year 21) voice recordings have been
introduced to capture in their own words the perspective of
very old people and their relatives or other carers on important
end-of-life issues, and qualitative research methods are adding
a further element to the wealth of quantitative data from the
study (Figure 4).
Proxy informant interviews
All study participants were interviewed in person at baseline, but
interviews with proxy informants were used in subsequent
surveys to minimize loss to follow-up that could under-represent
the frailest elderly.
Survey 1    Year 0    (n = 2609) 
Sample followed-up (n = 2165)
Survey 2 year 2 (n = 1179)
CAMDEX 1.1 year 0   (n = 530)
CAMDEX 1. 2 year 2 (n = 217)
CAMDEX 1.3 year 3   (n = 152) CAMDEX 2.1 year 3   (n = 463)
CAMDEX 2.2 year 5   (n = 300)
Survey 3 year 7 (n = 657)
Survey 4 year 10 (n = 446)
Survey 5 year 13 (n = 233)
Survey 6 year 17 (n = 110)
1985
CC75C Study design
CAMDEX 3.1 year 8   (n = 125)
1987
1988
1990
1992
1993
1995
1998
2002
Survey 7 year 21 (in progress) 2006
Year 0
Year 2
Year 3
Year 5
Year 7
Year 8
Year 10 
Year 13 
Year 17 
Year 21 
Figure 3 Flowchart illustrating the main phases in the CC75C study to date
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Retrospective informant interviews
Proxy informants are also interviewed, about study participants
who have died, in order to provide information about their
physical and mental health and their need for support services
in the period leading up to death. These interviews concern
those who became brain tissue donors when they died.
Table 2 summarizes the measures that were collected at
particular stages of the study.
What has the study found?
A full list of papers arising from the study, with
links to abstracts, can be found on the study website
(http://www.cc75c.group.cam.ac.uk). The study is one of the
first and largest prevalence studies of dementia and its sub-
types to be conducted in the United Kingdom.5 It has examined
the evolution of the earliest stages of dementia6,8 and optimal
patterns of care,7,18,19 The incidence study provided novel
findings on the incidence of dementia in the oldest old,13,14,20,21
the characterization of its sub-types22 and also evidence of
the continuous distributions of cognition and cognitive change
in population samples.23–26 The range and depth of neuro-
psychology assessments used have provided detailed evaluation
of clinically relevant measures.16,27 The neuropathological
findings demonstrated that there is much pathology in the
non-demented, and that this only relates loosely to clinical
status during life.28–30 This is a finding which is now
Table 2 Data collected at different study phases
Survey
Measure 1 2 3 4 5 6 7
Questionnaire data
Socio-demographics X X X X X X X
Family structure and
social support
X X X X X X X
Affect and loneliness – – X X X X X
Anxiety and depression X X X X X X X
Personal activities of
daily living
X X X X X X X
Instrumental activities of
daily living
X X X X X X X
Leisure activities and
social participation
X X X X X X X
Physical activity including
cycling
– – X X X X X
Driving – – – X – – –
Self-rated health and
reported diagnoses
X X X X X X X
Falls Xtf Xtf Xrf Xrf Xf Xff Xff
Medication X X X X X X X
Smoking and alcohol – – X X X X –
Assessments
Cognition –MMSE X X X X X X X
–CAMCOG
(incl. MMSE)
Xcc x Xcc½x Xcc½ Xcc Xcc Xcc Xcc
Hearing and eyesight X X X X X X X
Functional performance testing – – – – – X –
Physiological measures
Blood and saliva samples – – – X – – –
Magnetic resonance image
brain scans
– X – – – – –
Quantitative ultrasound heel scans – – – – – X –
Xtf tendency to fall.
Xrf recent falls.
Xff falls and fractures history.
Xcc x CAMCOG attempted with only participants selected for CAMDEX assessment groups.
Xcc½x CAMCOG attempted with onlyhalf participants interviewed plus CAMDEX groups.
Xcc CAMCOG attempted with all participants interviewed.
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well-replicated. Genetic studies have examined the role of
a number of candidate genes and polymorphisms in relation
to cognitive decline, dementia and particularly Alzheimer’s
disease.31–37 Researchers from a variety of disciplines have
reported such diverse findings as the prevalence of depression
amongst the older old,38–40 very old drivers,41 disability and
self-rated health42 and patterns of service use by the physically
and cognitively frail.19,43,44 Current work is building on earlier
survey findings concerning very old people’s views on
death.45,46 There is ongoing analysis on bone strength, falls
and their consequences in extreme old age.47,48
Main strengths
The cohort was based on a substantial proportion of those
aged 75 and over in Cambridge city at the time it began and,
with excellent response rates, is a highly representative sample.
From the outset, it included people living in institutions as well
as in the community, and the study continues to follow-up
individuals who have moved into care, an increasing proportion
of the sample over time. Whilst many of the older people
involved have always shown a keen interest in helping
research, recognition of all the participants’ contribution by
means of thank-you letters, newsletters, Christmas mailings
and certificates have been important in encouraging their
motivation to continue in the study. Proxy informant interviews
continue to enhance the data collection, and acknowledging
the role played by participants’ family, friends and other
carers is also important (Figure 4). The population has
been followed-up to a very advanced age, and it is planned to
follow-up individuals until the cohort has no living members.
The collection of brains from respondents is ongoing and those
individuals who die now contribute to the understanding of
the survival elite into the oldest age groups. Besides being so
representative, so long-running and including so many very
old people, the study’s other great strength is its wide range
of measures.
Main weaknesses
This very breadth of perspective inevitably has some limitations
as well—some measures are insufficiently detailed for certain
research questions, and changes in a few measures have led
to difficulties for particular longitudinal analyses. In common
with much epidemiological work, there has never been secure
core funding, thus the vagaries of grants awarded had
contributed to irregular follow-up intervals with loss to
follow-up in the earlier years of individuals who moved away,
limited the scope of costly biological measures and in part
contributed to some measurement changes as the focus of
enquiry shifted.
Can I get hold of data?
The study welcomes external collaborators and there are
mechanisms for submitting such research proposals to its
management committee. The wealth of data—from interviews,
assessments and the biological resources—have been archived
and would-be collaborators are encouraged to discuss data
requirements with the current study team.
Where can I find out more?
The study website (http://www.cc75c.group.cam.ac.uk) details
these collaborative mechanisms, gives full contact information
and list publications to date.
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